OtherAm J Transplant · March 2010
When new agents such as bortezomib appear, it is important to maintain scientific rigor regarding off-label use of medications. ...
Full textLink to itemCite
OtherNat Med · January 2001
Migratory cells can lead to both rejection and tolerance following organ transplantation, suggesting a direction for pro-tolerant immunomodulatory therapies. ...
Full textLink to itemCite